ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2017

More valuable than platinum: first-line pembrolizumab in advanced stage non-small-cell lung cancer.

T Zou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.